CIK: 0001536054 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $58,089 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 3,410,732 | $49,524 | 85.3% | $33.82 | -57.5% | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 1,820,937 | $6,464 | 11.1% | $21.17 | -82.9% | COM | 799566104 |
| EGHT | 8X8 INC NEW | 990,580 | $2,101 | 3.6% | $4.02 | -50.0% | COM | 282914100 |